CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 16 enrolled
Drug / intervention
Original Healing Salve (OHS) +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02394366
NCT02394366Phase 2Completed
CompareCT.gov

Effects of Topical Herbal Salve on Cutaneous Oxygenation and Peripheral Blood Flow

National University of Natural Medicine·interventional·Posted Mar 20, 2015·Updated Nov 8, 2018

In Brief

A Phase 2 clinical trial evaluating Original Healing Salve (OHS) and OHS base only for Skin Oxygenation and Peripheral Perfusion. Completed, enrolled 16 participants.

Detailed Summary

Delayed wound healing leads to increased risk for infection, and thus increased risk for morbidity and mortality. Skin oxygen delivery and peripheral blood flow predict wound healing. The investigators will conduct a double-masked, placebo-controlled cross-over clinical pilot trial in order to evaluate the effects of a topical, homeopathic/herbal salve (Original Healing Salve, Puremedy, Inc.) on skin oxygenation and peripheral blood flow.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Oxygenation, Peripheral Perfusion
Countries--
Collaborators--

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 20, 2015
Enrollment StartMar 1, 2015
Primary CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 11.3 years ago

Interventions

Original Healing Salve (OHS)other

Topical salve (Puremedy, Inc.)

OHS base onlyother

Olive and beeswax salve base